These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18644610)

  • 1. Data safety and monitoring boards for African clinical trials.
    Lang T; Chilengi R; Noor RA; Ogutu B; Todd JE; Kilama WL; Targett GA
    Trans R Soc Trop Med Hyg; 2008 Dec; 102(12):1189-94. PubMed ID: 18644610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data and safety monitoring policy for National Institute of Allergy and Infectious Diseases clinical trials.
    Dixon DO; Weiss S; Cahill K; Fox L; Love J; McNamara J; Soto-Torres LE
    Clin Trials; 2011 Dec; 8(6):727-35. PubMed ID: 22024105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data safety monitoring boards: legal and ethical considerations for research accountability.
    Tereskerz PM
    Account Res; 2010 Jan; 17(1):30-50. PubMed ID: 20094929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International collaboration, funding and association with burden of disease in randomized controlled trials in Africa.
    Swingler GH; Pillay V; Pienaar ED; Ioannidis JP
    Bull World Health Organ; 2005 Jul; 83(7):511-7. PubMed ID: 16175825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the data safety and monitoring board in an international trial.
    NIMH Collaborative HIV/STD Prevention Trial
    AIDS; 2007 Apr; 21 Suppl 2():S99-102. PubMed ID: 17413269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiences and challenges in data monitoring for clinical trials within an international tropical disease research network.
    Chen-Mok M; VanRaden MJ; Higgs ES; Dominik R
    Clin Trials; 2006; 3(5):469-77. PubMed ID: 17060220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board.
    Wittes J; Barrett-Connor E; Braunwald E; Chesney M; Cohen HJ; Demets D; Dunn L; Dwyer J; Heaney RP; Vogel V; Walters L; Yusuf S
    Clin Trials; 2007; 4(3):218-34. PubMed ID: 17715247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DSMB. 2. The importance of an efficient DSMB: some examples of high-risk clinical trials].
    Brun-Buisson C
    Med Sci (Paris); 2005 Feb; 21(2):187-9. PubMed ID: 15691491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-based interventions for neurologic conditions: ethical challenges for early human trials.
    Mathews DJ; Sugarman J; Bok H; Blass DM; Coyle JT; Duggan P; Finkel J; Greely HT; Hillis A; Hoke A; Johnson R; Johnston M; Kahn J; Kerr D; Kurtzberg J; Liao SM; McDonald JW; McKhann G; Nelson KB; Rao M; Regenberg A; Siegel AW; Smith K; Solter D; Song H; Vescovi A; Young W; Gearhart JD; Faden R
    Neurology; 2008 Jul; 71(4):288-93. PubMed ID: 18463365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DSMB. 1. What role, what responsibilities?].
    Brun-Buisson C
    Med Sci (Paris); 2005 Jan; 21(1):78-82. PubMed ID: 15639025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory perspectives on data safety monitoring boards: protecting the integrity of data.
    Hemmings R; Day S
    Drug Saf; 2004; 27(1):1-6. PubMed ID: 14720083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data handling in clinical trials: an ongoing debate.
    Jongen PJ
    Mult Scler; 1995; 1 Suppl 1():S60-3. PubMed ID: 9345402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An opinion and practice survey on the structure and management of data and safety monitoring boards.
    Tereskerz PM; Guterbock TM; Kermer DA; Moreno JD
    Account Res; 2011 Jan; 18(1):1-30. PubMed ID: 21287412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data safety monitoring boards: a word from a sponsor (NHLBI).
    Mondoro TH
    Transfusion; 2009 Aug; 49(8):1537-9. PubMed ID: 19413736
    [No Abstract]   [Full Text] [Related]  

  • 15. Research review boards dogged by criticism.
    Ledford H
    Nature; 2009 Apr; 458(7238):557. PubMed ID: 19340042
    [No Abstract]   [Full Text] [Related]  

  • 16. Committee for Medicinal Products for Human Use (CHMP) guideline on Data Monitoring Committees.
    ; ;
    Stat Med; 2006 May; 25(10):1639-45. PubMed ID: 16639775
    [No Abstract]   [Full Text] [Related]  

  • 17. An introductory note to CHMP guidelines: choice of the non-inferiority margin and data monitoring committees.
    Brown D; Volkers P; Day S
    Stat Med; 2006 May; 25(10):1623-7. PubMed ID: 16639776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From research to control: Translating research findings into health policies, operational guidelines and health products.
    Kilama W
    Acta Trop; 2009 Nov; 112 Suppl 1():S91-S101. PubMed ID: 19686696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards an African-driven malaria vaccine development program: history and activities of the African Malaria Network Trust (AMANET).
    Kilama WL; Chilengi R; Wanga CL
    Am J Trop Med Hyg; 2007 Dec; 77(6 Suppl):282-8. PubMed ID: 18165504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should statisticians reporting to data monitoring committees be independent of the trial sponsor and leadership?
    Ellenberg SS; George SL
    Stat Med; 2004 May; 23(10):1503-5. PubMed ID: 15122727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.